{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:11:29Z","timestamp":1792174289247,"version":"4.4.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00120246 \/ WB-2021-36350, 00154900 \/ WB-2024-54768"],"award-info":[{"award-number":["00120246 \/ WB-2021-36350, 00154900 \/ WB-2024-54768"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The apicomplexan parasite <jats:italic>Toxoplasma gondii<\/jats:italic> establishes chronic infection in the central nervous system, including the retina, causing ocular toxoplasmosis (OT). This persistence relies on a fine balance between inflammatory and immunomodulatory mechanisms, especially in the immune-privileged ocular environment. We previously described the immunologic interactions between retinal cells, and particularly the roles of type I and III interferons. In this study, we investigated the regulatory dynamics of PD-L1, a central immunomodulatory receptor on immune cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We first investigated the mechanisms of PD-L1 regulation and the roles of type I and III interferons in an <jats:italic>in vitro T. gondii<\/jats:italic> infection model using mono- and co-culture systems of human microglia, astrocytes, and M\u00fcller cells. We also assessed PD-L1 expression in an outer blood-retina barrier model (oBRB) of differentiated retinal pigmented epithelial (RPE) cells. Additionally, we looked at retinal cell activation, PD-L1 expression and the roles of these interferons in a mouse model of OT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings reveal new roles for type I and III interferons in regulating glial cell activation and PD-L1 expression in RPE, M\u00fcller, astrocytes and microglial cells. Notably, M\u00fcller cells, the most abundant glial cells in the retina, showed the highest baseline PD-L1 expression at both the mRNA and protein levels, and responded robustly to interferon stimulation. This points to a more prominent immunoregulatory role for M\u00fcller cells in the retina than previously recognized.  Furthermore, we identified a parasite protease-dependent mechanism that reduces PD-L1 expression in our <jats:italic>in vitro<\/jats:italic> oBRB model potentially contributing to immune evasion and inflammation during OT. Finally, in a murine model of OT, we demonstrated that PD-L1 expression reached its peak on day 7 post-infection and that interferon neutralization plays a crucial role in regulating both PD-L1 expression and glial activation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The parasite <jats:italic>T. gondii<\/jats:italic> orchestrates the IFN type I and III dependent retinal immune interaction and downregulates PD-L1 in the oBRB by a protease-dependent mechanism, potentially contributing to immune evasion and inflammation in retinal infection. Our results can pave the way to fully elucidate retinal immune networks and PD-L1 regulation mechanisms, offering potential targets for therapeutic interventions in OT and other retinal inflammatory diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1607247","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:18Z","timestamp":1750138098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Interferons and Toxoplasma gondii shape PD-L1 regulation in retinal barrier cells: the critical role of proteases"],"prefix":"10.3389","volume":"16","author":[{"given":"Benjamin","family":"Geiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Cevallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliia","family":"Tsybenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Arnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Felder-Schmittbuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Pfaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"134261","DOI":"10.1080\/09273948.2022.2117705","article-title":"Ocular toxoplasmosis","volume":"31","author":"Goh","year":"2023","journal-title":"Ocular Immunol Inflammation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"43452","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","first-page":"348492","DOI":"10.1128\/IAI.00117-10","article-title":"CD4 T-cell suppression by cells from toxoplasma gondii-infected retinas is mediated by surface protein PD-L1","volume":"78","author":"Charles","year":"2010","journal-title":"Infect Immun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1356216","article-title":"IFNs in host defence and parasite immune evasion during Toxoplasma gondii infections","volume":"15","author":"L\u00fcder","year":"2024","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"90723","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2019.07.007","article-title":"Differential activation of the transcription factor IRF1 underlies the distinct immune responses elicited by type I and type III interferons","volume":"51","author":"Forero","year":"2019","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1016\/j.immuni.2019.08.019","article-title":"Why is IFN-\u03bb Less inflammatory? One IRF decides","volume":"51","author":"Casazza","year":"2019","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"152389","DOI":"10.1016\/j.imbio.2023.152389","article-title":"PD-L1 and PD-L2 immune checkpoint protein induction by type III interferon in non-small cell lung cancer cells","volume":"228","author":"Larsen","year":"2023","journal-title":"Immunobiology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148037","article-title":"Type I and III interferons shape the retinal cytokine network and barrier function in an in vitro model of ocular toxoplasmosis","volume":"14","author":"Geiller","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.v12.12","article-title":"Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis","volume":"12","author":"Ferreira","year":"2023","journal-title":"Clin Transl Immunol"},{"key":"B11","article-title":"In vitro characterization of a spontaneously immortalized human M\u00fcller cell line (MIO-M1)","volume":"43","author":"Limb","year":"2002","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.exer.2018.10.009","article-title":"Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide","volume":"179","author":"Hazim","year":"2019","journal-title":"Exp Eye Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12929-020-00670-x","article-title":"The impact of PD-L1\u2009N-linked glycosylation on cancer therapy and clinical diagnosis","volume":"27","author":"Wang","year":"2020","journal-title":"J Biomed Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13283","article-title":"Toxoplasma gondii excreted\/secreted proteases disrupt intercellular junction proteins in epithelial cell monolayers to facilitate tachyzoites paracellular migration","volume":"23","author":"Ram\u00edrez-Flores","year":"2021","journal-title":"Cell Microbiology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214310","article-title":"Type I ROP16 regulates retinal inflammatory responses during ocular toxoplasmosis","volume":"14","author":"Rochet","year":"2019","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1016\/j.celrep.2019.05.051","article-title":"Robust control of a brain-persisting parasite through MHC I presentation by infected neurons","volume":"27","author":"Salvioni","year":"2019","journal-title":"Cell Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1080\/713774061","article-title":"Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells","volume":"9","author":"Eppihimer","year":"2002","journal-title":"Microcirculation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"35970","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2597605","DOI":"10.1007\/s00436-018-5950-3","article-title":"Investigation of tissue cysts in the retina in a mouse model of ocular toxoplasmosis: distribution and interaction with glial cells","volume":"117","author":"Song","year":"2018","journal-title":"Parasitol Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054358","article-title":"Toxoplasma gondii migration within and infection of human retina","volume":"8","author":"Furtado","year":"2013","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.771571","article-title":"Proteomic phenotyping of stimulated m\u00fcller cells uncovers profound pro-inflammatory signaling and antigen-presenting capacity","volume":"12","author":"Schmalen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/ijmm.2024.5369","article-title":"Role of microglia\/macrophage polarisation in intraocular diseases (Review)","volume":"53","author":"Li","year":"2024","journal-title":"Int J Mol Med mai"},{"key":"B23","doi-asserted-by":"publisher","first-page":"120612","DOI":"10.1159\/000531156","article-title":"Relationship between uveitis and the differential reactivity of retinal microglia","volume":"66","author":"Gao","year":"2023","journal-title":"Ophthalmic Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"12419","DOI":"10.1189\/jlb.0610332","article-title":"PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells","volume":"88","author":"Ke","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1051\/parasite\/2018025","article-title":"Metallopeptidases of Toxoplasma gondii: in silico identification and gene expression","volume":"25","author":"Escotte-Binet","year":"2018","journal-title":"Parasite"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/s41467-022-31720-7","article-title":"The intrinsically disordered protein TgIST from Toxoplasma gondii inhibits STAT1 signaling by blocking cofactor recruitment","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1748091","DOI":"10.1073\/pnas.1904637116","article-title":"Toxoplasma gondii effector TgIST blocks type I interferon signaling to promote infection","volume":"116","author":"Matta","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662944","article-title":"Intravacuolar pathogens hijack host extracellular vesicle biogenesis to secrete virulence factors","volume":"12","author":"Gioseffi","year":"2021","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13071-022-05429-x","article-title":"Activation of NF-\u03baB signaling by the dense granule protein GRA15 of a newly isolated type 1 Toxoplasma gondii strain","volume":"15","author":"Guo","year":"2022","journal-title":"Parasites Vectors"},{"key":"B30","doi-asserted-by":"publisher","first-page":"489500","DOI":"10.1016\/j.chom.2013.03.002","article-title":"Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression","volume":"13","author":"Bougdour","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B31","doi-asserted-by":"publisher","first-page":"20033","DOI":"10.1038\/s41598-024-68401-y","article-title":"Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis","volume":"14","author":"Quinn","year":"2024","journal-title":"Sci Rep"},{"key":"B32","unstructured":"Geiller\n              B\n            \n          \n          Strasbourg, France\n          Universit\u00e9 de Strasbourg\n          L\u2019immunoprivil\u00e8ge dans la toxoplasmose oculaire: r\u00f4le des Interf\u00e9rons de types I et III et de PD-L1 dans la dynamique de l\u2019infection\n          \n          2025"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:21Z","timestamp":1750138101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2025.1607247"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1607247","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1607247"}}